Sign in
Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
Journal article   Open access  Peer reviewed

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration

Mark Nestor, Glynis Ablon and Andy Pickett
Aesthetic surgery journal, Vol.37(suppl_1), pp.S20-S31
2017-05-01
PMCID: PMC5434495
PMID: 28388717

Abstract

Age Factors Botulinum Toxins, Type A - pharmacokinetics Humans Skin Aging - drug effects Treatment Outcome Clinical Trials as Topic Acetylcholine Release Inhibitors - administration & dosage Cosmetic Techniques - trends Botulinum Toxins, Type A - administration & dosage Acetylcholine Release Inhibitors - pharmacology Patient Satisfaction Acetylcholine Release Inhibitors - pharmacokinetics Botulinum Toxins, Type A - pharmacology Cosmetic Techniques - standards Facial Muscles - drug effects Facial Muscles - physiology Time Factors Face - anatomy & histology Injections, Intramuscular - methods Practice Guidelines as Topic Therapeutic Equivalency
url
https://doi.org/10.1093/asj/sjw282View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.247 Migraines & Headaches
1.247.1001 Dystonia
Web Of Science research areas
Surgery
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details